Navigation Links
ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
Date:1/8/2009

ge biopharmaceutical company dedicated to improving patient care by developing novel medicines in the areas of hepatitis C and oncology. For the treatment of chronic hepatitis C, the Company is developing two potentially complementary agents, ANA598, a non-nucleoside polymerase inhibitor and ANA773, an oral TLR7 agonist prodrug. The Company is also developing ANA773 for the treatment of cancer.

Safe Harbor Statement

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, references to (i) the potency, safety and tolerability profile of ANA598, which may not be duplicated in future cohorts at higher doses or future clinical studies of longer duration; (ii) the belief that ANA598 is a leading non-nucleoside polymerase inhibitor in development for the treatment of HCV and the ability to use ANA598 in combination with other anti-HCV agents in the future; (iii) the potential for once-daily or twice-daily oral dosing of ANA598; (iv) the ability of Anadys to transition into Phase II studies of ANA598 during 2009; and (v) expectations regarding the evolution of the market for HCV therapies. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Anadys' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. For example, the results of preclinical and early clinical studies (including those described in this press release) may not be predictive of future results, and Anadys cannot provide any assurances that ANA598 will not have unforeseen safety issues, will have favorable results in future cohorts of the Phase Ib study or future clinical trials, will maintain fast track designation or will receive regulatory approval. In addition, Anadys' results may be
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
6. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
7. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
8. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
9. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
10. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
11. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015 ... announced the addition of the  "US Cancer ... their offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... into to two broad categories of prophylactic ... cancer vaccines belong to both of these ...
(Date:5/27/2015)... 26, 2015 Research and Markets( http://www.researchandmarkets.com/research/ljsxt8/asia_pacific ) has ... Ray Devices Market - Growth, Trends And Forecasts (2014 - ... Asia Pacific market for Portable X-Ray ... 2014 to 2020 X-Ray is a form of ... the body, especially bones. The need of point of care ...
(Date:5/27/2015)... Research and Markets( http://www.researchandmarkets.com/research/nt9zlx/asia_pacific ) has announced ... - Growth, Trends And Forecasts (2014 - 2019)" ... a detailed type of imaging that customs a low-dose ... a mammogram, is used to support in the early ... x-ray (radiograph) is a noninvasive medical test that helps ...
Breaking Medicine Technology:US Cancer Vaccine Market Outlook 2020 2US Cancer Vaccine Market Outlook 2020 3Asia Pacific Portable X Ray Devices Market 2015 - Trends And Forecasts to 2019 2Asia Pacific Mammography Market Trends and Forecasts 2015-2019 2
(Date:5/27/2015)... (PRWEB) May 27, 2015 Genius Monkey ... their advanced programmatic marketing technology, they have boosted sales ... support on a regional level for seven Utah-based dealers. ... was through television and radio media. In 2014 the ... the help of Genius Monkey , shifted their ...
(Date:5/27/2015)... With InnerVoice Communication App you will ... is not only heard but seen -- by a photograph ... image. This award-winning and affordable app takes full advantage of ... InnerVoice Sender app in conjunction with InnerVoice Communication ... remotely for no additional cost. , InnerVoice Sender ...
(Date:5/27/2015)... 27, 2015 With a prevalently high ... conducted during the "ACA - Controlling the Chaos" webinar ... are currently in the process of researching ACA ... confidently prepared for the reporting mandates. , According to ... webinar, those who are currently vetting ACA reporting solutions ...
(Date:5/27/2015)... http://www.smarterskindermatology.com , is taking skin care customization to a ... for patients to find skin care products that work specifically ... a cosmetic dermatologist based in New York and is the ... DNA test uses 16 genetic markers to evaluate the following ... Firmness and elasticity , 2. Glycation , 3. Sun damage ...
(Date:5/27/2015)... 27, 2015 Decorview , a ... is offering free design advice to homeowners looking to ... , “Light pollution caused by streetlights, outdoor signs, full ... night’s sleep, said Kim Rush, VP of sales and ... across North America with recently installed LED streetlights– the ...
Breaking Medicine News(10 mins):Health News:Genius Monkey Boosts Utah Honda Dealers Website Traffic 142% 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 3Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 4Health News:Employers are On Track for ACA Reporting According to Businessolver Poll 2Health News:SmarterSkin Dermatology is Now Offering Skin DNA Analysis 2Health News:Decorview Helps Homeowners Combat Light Pollution 2
... students to surgeons, anyone who has pulled an all-nighter knows ... trouble focusing, a fuzzy memory and other cognitive impairments. ... brain and the neurochemical basis for sleep deprivation,s effects on ... Penn,s School of Arts and Sciences and director of the ...
... By Jenifer Goodwin HealthDay Reporter , TUESDAY, ... Drug Administration advisory committees plan to meet Tuesday and ... instructions on the labels of medicines containing acetaminophen need ... of 2 against possible liver failure and even death. ...
... By Amanda Gardner HealthDay Reporter , TUESDAY, ... 30 percent of their hospital emergency rooms in the past ... than 35 percent, new research shows. And the closures ... who are poor, publicly insured or uninsured -- people without ...
... 17, 2011 -- In New York City, the prevalence ... anywhere from 3% to 19%, and children growing up ... fold differences in risk for having asthma. In ... localized differences, researchers at Columbia University,s Mailman School of ...
... A study conducted at the University of Arizona College ... clinical decision support software systems the computer programs ... medication problems correctly identified potentially dangerous drug-drug interactions. ... Arizona. Members of the research team tested the pharmacy ...
... News) -- A gene variation that causes faulty cholesterol regulation ... and may be a reason why some women can,t get ... at more than 200 infertile women who were undergoing in ... of the scavenger receptor class B type 1 (SCARB1) gene. ...
Cached Medicine News:Health News:Penn researchers identify the roots of memory impairment resulting from sleep deprivation 2Health News:Penn researchers identify the roots of memory impairment resulting from sleep deprivation 3Health News:FDA Panels to Weigh Dosing Labels for Kids' OTC Fever Relievers 2Health News:FDA Panels to Weigh Dosing Labels for Kids' OTC Fever Relievers 3Health News:FDA Panels to Weigh Dosing Labels for Kids' OTC Fever Relievers 4Health News:Almost 30% of Urban ERs Closed During Past Two Decades: Study 2Health News:Almost 30% of Urban ERs Closed During Past Two Decades: Study 3Health News:Cockroach allergens in homes associated with prevalence of childhood asthma in some neighborhoods 2Health News:Gene Variation May Explain Some Female Infertility Cases 2
MiniCycler thermal cycler with Hot Bonnet heated lid, holds 16x0.5ml tubes...
Dual-bay Dyad thermal cycler chassis, does not include the Alpha units (requires 2)...
... Sprint with 24-well x 0.2ml sub-ambient block ... tube thermistor) Heating rates: up to 3C/second; ... 4-99C; Excellent uniformity: better than 0.5C within ... use programming: directory program storage of up ...
... an inexpensive personal or mini thermal cycler, and ... with a small footprint, it can be easily ... desk. , The Gene Cycler thermal cycler meets ... access to a large laboratory thermal cycler, or ...
Medicine Products: